PATH vs STE
Uipath Inc (PATH) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
PATH currently screens at market cap $6.07B and trailing P/E 19.4. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the PATH and STE stock pages for the full models.
Not investment advice.